Chief Financial Officer and Secretary · Evofem Biosciences, Inc. (EVFM)

Ivy Zhang

A named executive officer of Evofem Biosciences in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$695,261

Salary $450,000Stock awards $0Bonus $243,750

FY2023: $438,849

2nd of 2 named executive officers at Evofem Biosciences by FY2024 total.

2 named officers on file for Evofem Biosciences, FY2024

Ivy Zhang’s pay file — $29

  • 2 fiscal years of pay, line by line
  • EVFM’s disclosed peer group of 24 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Evofem Biosciences’s whole pay program stands against its peers

  • Evofem Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on EVFM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 29, 2025 (DEF 14A).

Free

Get Ivy Zhang’s full pay file as a PDF — free

More than this page: up to 10 years of Ivy’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Ivy Zhang compensation by year

Evofem Biosciences Summary Compensation Table · all 2 fiscal years held
In US dollars, as Evofem Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$293,570$450,000
Bonus$94,439$243,750
Stock awards$0$0
Option awards$0$0
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$50,840$1,511
Total$438,849$695,261

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Evofem Biosciences, Inc. DEF 14A filed October 29, 2025, accession 0001493152-25-020062, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Evofem Biosciences, Inc. filed document, accession 0001493152-25-020062. Every figure is read from that document and cited to the page and table it appears in. Filed October 29, 2025.

$439K
$695K
FY23
FY24
SalaryBonusAll other

Evofem Biosciences’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Saundra PelletierChief Executive Officer$1,177,838
Ivy Zhang · this pageChief Financial Officer and Secretary$695,261

The full Evofem Biosciences compensation record

free company brief

This page is one person within Evofem Biosciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Evofem Biosciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Evofem Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Ivy Zhang's compensation dossier · One-time report. No refunds.